Clearside Biomedical, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Alparetta Georgia (2011)

Organization Overview

First Clinical Trial
2013
NCT01789320
First Marketed Drug
2021
triamcinolone (kenalog)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CLEARSIDE | Clearside Biomedical, Inc.